The Compass Fall 2020 | Page 5

… ponsored by Eli Lilly first monoclonal Regeneron. The re, however; e than 20 new rch studies that aim derstand and battle an additional study being investigated by Thomas Cox, PsyD, director of faculty development and education research in graduate medical education at Baylor University Medical Center, on the risk of suicide for medical clinicians and physicians during and after a pandemic. se important h initiatives include rials targeting ation caused by s, research focused a antibodies, and geting the virus itself. itionally, the 9 research is committed rstanding the ogical impact this ic has on society philanthropically studies that will help nd how individuals mental resilience by Ann Marie center director for SWRI, these initiatives data on more than will investigate the logical symptoms, nxiety, depression ress disorder as 9 pandemic. They y in those subjects ng despite the find ways to bring Communities rovided a generous second phase h, and to support Funding the Innovation Extending investigational expertise across more than 50 medical specialties, Baylor Scott & White Research Institute provides the business and regulatory expertise to accelerate medical breakthroughs and innovative new treatment models through clinical and translational activities. At outpatient sites and hospitals across the System, BSWRI conducts nearly 2,000 active trials each year. For decades, BSW Dallas Foundation has received generous support from donors to help advance clinical trials and investigator-initiated studies. Without this donor support and Baylor Scott & White’s dedication and commitment to advancing healthcare through research, these potentially lifesaving trials would not be possible. “It’s so important for people to get involved and help fund studies like these,” said Dr. Mack. “This is critical research that is going to not only help beat this virus but in addition make an impact on the way we practice healthcare in the future.” For more information on opportunities to help fund research that will advance the care for COVID-19 and beyond, please contact Sarah Burdi at 214.820.4721 or [email protected]. White Research Institute is uniquely prepared to help fight this pandemic because of its infrastructure and experience with similar experimental research efforts.